PRMT1 and rheumatoid arthritis: Dysregulation of PRMT1 activity and expression is significantly associated with the pathogenesis of various immune‐mediated diseases, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), asthma, and chronic graft‐versus‐host disease (cGVHD).